People: Fourth Bristol-Myers Squibb Pain Award Is Presented To UNC Nociceptor Pioneer

Edward R. Perl, Sarah Graham Kenan Professor of Physiology at the University of North Carolina, Chapel Hill, is the recipient of the fourth annual Bristol-Myers Squibb Award for Distinguished Achievement in Pain Research. The award, which consists of a $50,000 prize and a silver medallion, was presented to Perl in November at the annual meeting of the American Pain Society in New Orleans. Perl, 64, was recognized for his discovery of nociceptors, nerve endings in skin and tissue that convey i

Written byBarbara Spector
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Perl, 64, was recognized for his discovery of nociceptors, nerve endings in skin and tissue that convey information about pain-causing stimuli, and for his finding that nociceptors engage some specific central neural mechanisms. He also found that nociceptors have the ability to become sensitized to repeated stimulation, so that normally nonpainful actions, such as the touch of a hand, cause pain--for example, in cases of sunburn.

Nociceptors--so named because they detect noxious stimuli--were first hypothesized to exist at the turn of the century by Sir Charles Sherrington, who won the Nobel Prize in medicine or physiology in 1932. "The basic problem," says Perl, "was that no one had found these. Sherrington's prediction had been forgotten over the years; no one had used that line of thinking." In the mid-1960s, Perl recalls, while he and colleague P.R. Burgess were "in the process of doing a systematic analysis of sensory fibers" at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies